Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
682,819
-
Shares change
-
-177,853
-
Total reported value, excl. options
-
$4,718,007
-
Value change
-
-$1,382,287
-
Number of buys
-
3
-
Number of sells
-
-12
-
Price
-
$6.91
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q2 2020
21 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q2 2020.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 682,819 shares
of 52,664,292 outstanding shares and own 1.3% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (228,193 shares), BlackRock Inc. (214,142 shares), AlphaCentric Advisors LLC (100,000 shares), GEODE CAPITAL MANAGEMENT, LLC (50,504 shares), RENAISSANCE TECHNOLOGIES LLC (35,400 shares), Bank of New York Mellon Corp (19,690 shares), Steward Partners Investment Advisory, LLC (15,600 shares), NORTHERN TRUST CORP (12,743 shares), MORGAN STANLEY (4,663 shares), and WELLS FARGO & COMPANY/MN (1,202 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.